the aid library

LIST OPTIONS

Filter

2868

Download (558)

View PDF (914)

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1

Download (678)

View PDF (783)

Democratic Republic of the Congo. Demographic and Health Survey 2013-14.Supplemental V accine -preventable Diseases Report

A. Rimoin; E. Okitolonda; R. Doshi; et al. USAID; WHO; PEPFAR; et al. (2015) C1

Download (274)

View PDF (317)

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
recommended

World Health Organization WHO (2021) C_WHO

23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health... more

Download (1528)

View PDF (4126)

Clinical care for survivors of Ebola virus disease
recommended

World Health Organization (WHO) (2016) C_WHO

Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ... more

Download (366)

View PDF (557)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (288)

View PDF (441)

Disease Control Priorities 3: Palliative Care and Pain Control

World Bank (2018) C1

Palliative care has been shown to provide significant and diverse benefits for patients with serious, complex,or life-limiting health problem. Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R., editors. Disease Control Priorities, 3rd Edition, Volume 9: Improving Health an... more

Download (246)

View PDF (502)

Plan of Action for the prevention and control of HIV and sexually transmitted infections 2016-2021

Pan American Health Organization (PAHO) (2016) C_WHO

External Link

Molecular and Clinical Aspects of Chronic Manifestations in Chagas Disease: A State-of-the-Art Review

Medina-Rincón, G.; Gallo-Bernal, S.; Jiménez, P.; et al. (2021) CC

Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493 .Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech... more

Download (1202)

View PDF (2366)

Clinical management of patients in the Ebola Treatment Centres and other care centres in Sierra Leone

Ministry of Health and Sanitation Sierra Leone; World Health Organization (2015)

Interim emergency guidelines

Download (262)

View PDF (415)

Interruption of transmission and elimination of leprosy disease - Technical guidance

World Health Organisation (WHO) (2023) C_WHO

This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p... more

Download (437)

View PDF (763)

Democratic Republic of the Congo (DRC): Ebola virus disease outbreak - Emergency Plan of Action Operations Update n°3 (MDRCD026)

International Federation of Red Cross And Red Crescent Societies IFRC (2018) C1

Download (603)

View PDF (862)

Epidemiological review of TB disease in Sierra Leone

L. Anderson and E. Hamblion World Health Organisation (WHO) (2015) C_WHO

Download (1273)

View PDF (2132)

Support Services for Survivors of Ebola Virus Disease — Sierra Leone, 2014

Seung Hee Lee-Kwan, et al. (2014)

MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206

Download (359)

View PDF (528)

Applying a One Health Approach in Global Health and Medicine: Enhancing Involvement of Medical Schools and Global Health Centers

Machalaba, C.; et al. (2021) CC

Annals of Global Health, 87(1), p.30. DOI: http://doi.org/10.5334/aogh.2647

Download (1022)

View PDF (1243)

An Advocacy Strategy for Adoption and Dissemination of the WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households

D’Arcy Richardson, PATH, and Greg Pirio, Empower Communications USAID, StopTBPartnership (2010) C2

Recommended actions and international and national level

Download (416)

View PDF (567)

The Impact of Tuberculosis among Immigrants: Epidemiology and Strategies of Control in High-Income Countries—Current Data and Literature Review

C. Contini, M. Maritari, M. die Nuzzo, et al. INTECH (2017) CC

World's largest Science, Technology & Medicine Open Access book publisher Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits

Download (229)

View PDF (246)

An Advocacy Strategy for Adoption and Dissemination of the WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Household

D’A. Richardson; G. Pirio; et al. USAID; Stop TB Partnership; TB online (2010) C2

Recommended actions at international and national levels

External Link

Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015.

Walker, N.F.; et al. (2015)

Euro Surveill. 2015 Mar 26;20(12). pii: 21073.

Download (433)

View PDF (558)

Tool for the diagnosis and care of patients with suspected arboviral diseases

Pan American Health Organization PAHO ; World Health Organization WHO (2017) C_WHO

It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10... more

External Link

Rationality of drug prescriptions in rural health centres in Burkina Faso

Krause G., M. Borchert, J. Benzler et al. Health policy and planning (1999) C2

Burkina Faso has approximately 10.5 million inhabitants and is divided into 30 provinces. The study took place in the districts of Tougan, Nouna, and Solenzo, in provinces Sourou and Kossi, in north-west Burkina Faso. There is one medical centre in every district capital and 6 to 14 health centres i... more

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages recommended

Clinical care for survivors of Ebola virus disease recommended

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
recommended

Clinical care for survivors of Ebola virus disease
recommended